| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |